Pinelli P, Trivulzio S, Colombo R, Cocchi D, Faravelli R, Caviezel F, Galmozzi G, Cavallaro R
Department of Pharmacology, University of Milan, Italy.
Agents Actions. 1987 Dec;22(3-4):197-201. doi: 10.1007/BF02009046.
Administration of large doses of cimetidine for 45 days to rats decreases the weight of the prostate and seminal vesicles without affecting the testicles. The decrease in weight is due to a marked regression in the prostate of both epithelial and stromal tissue. Treatment with cimetidine also causes an increase in the plasma testosterone level without modifying the plasma values of LH and prolactin. The mechanism of action of cimetidine is discussed. In presence of high levels of testosterone, cimetidine depresses structures such as the prostate and seminal vesicles, which are sensitive to androgens, but does not depress the weight or change the histology profile of the testicles, which are also rich in androgen receptors. Perhaps cimetidine binds to androgen receptors differently in the prostate and in the testicles because of differences in receptor structure or more probably, cimetidine interacts with zinc metal ion essential to prostate growth and androgen action by lowering zinc prostatic levels and consequently depresses the prostatic weight.
给大鼠大剂量服用西咪替丁45天,可使前列腺和精囊重量减轻,而不影响睾丸。重量减轻是由于前列腺上皮和基质组织显著退化。西咪替丁治疗还会使血浆睾酮水平升高,而不改变血浆促黄体生成素和催乳素的值。讨论了西咪替丁的作用机制。在高睾酮水平下,西咪替丁会抑制对雄激素敏感的结构,如前列腺和精囊,但不会抑制富含雄激素受体的睾丸的重量或改变其组织学特征。也许西咪替丁在前列腺和睾丸中与雄激素受体的结合方式不同,这是由于受体结构的差异,或者更有可能的是,西咪替丁通过降低前列腺锌水平与前列腺生长和雄激素作用所必需的锌金属离子相互作用,从而降低前列腺重量。